74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Alcon Inc
Closed
SectorHealthcare
92.5 -0.03
Overview
Share price change
24h
Min
91.56
Max
92.68
Income | 21M 284M |
|---|---|
Sales | 48M 2.5B |
P/E Sector Avg | 46.307 63.778 |
EPS | 0.72 |
Dividend yield | 0.28 |
Profit margin | 11.351 |
Employees | 25,599 |
EBITDA | 56M 397M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +13.2% upside |
Dividend yield Sector Avg | 0.28% 2.39% |
|---|---|
Next Earnings | 13 May 2025 |
Market Cap | 5.9B 47B |
|---|---|
Previous open | 92.53 |
Previous close | 92.5 |
News Sentiment
By Acuity
50%
50%
173 / 386 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Alcon Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Alcon Inc Forecast
Price Target
By TipRanks
13.2% upside
12 Months Forecast
Average 107.46 USD 13.2%
High 120 USD
Low 90 USD
Based on 20 Wall Street analysts offering 12 month price targets forAlcon Inc - Dist in the last 3 months.
Sentiment
By Acuity
173 / 386 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Alcon Inc
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
